Existing core facilities for Oligonucleotide synthesis and for DNA Sequencing will be further supported by funds from the Research Center in Oral Biology, in order to obtain expedited services for members of the RCOB. All of the projects have a need for oligonucleotides, especially for PCR amplification and quantitation. In addition, Project 5 will require large quantities of anti-sense oligonucleotides for gene expression experiments. Project 6 will require oligonucleotides for DNA sequencing of PCR amplified DNAs or of mutants created by site-directed mutagenesis. All of the projects will have access to computer programs and to nucleotide and protein databases for analysis of DNA and protein sequences. The Oligonucleotide Synthesis Core Facility operates an Applied Biosystems Model 394 four column DNA synthesizer and provides custom synthesized oligonucleotides for DNA sequencing, PCR amplification, and site-directed mutagenesis. Charges for synthesis are kept as low as possible and are designed to recover only the reagent costs. Oligonucleotides are generally available with 24 to 48 hours of synthesis; additional purification by HPLC is available at no extra charge and adds approximately 1 to 2 days to the time required for delivery of the product. The DNA Sequencing Core Facility operates on Applied biosystems Model 373A automated DNA sequencer and a Perkin-Elmer Model 9600 Thermocycler. In addition, this core facility provides access to computer programs for analysis of DNA and protein sequences; these programs are leased on a yearly basis from the Genetics Computer Group, Inc. In addition, GENBANK and EMBL nucleotide sequence databases and Swiss-prot and NBRF protein databases are provided; the information in these resources are updated on a quarterly basis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
2P50DE008228-06
Application #
3775824
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Windsor, L Jack; Steele, Darin L (2010) Expression of recombinant matrix metalloproteinases in Escherichia coli. Methods Mol Biol 622:67-81
Katz, Jannet; Yang, Qiu-Bo; Zhang, Ping et al. (2002) Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains. Infect Immun 70:2512-8
Smith, P D; Smythies, L E; Mosteller-Barnum, M et al. (2001) Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167:2651-6
Aznavoorian, S; Moore, B A; Alexander-Lister, L D et al. (2001) Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 61:6264-75
Hirschfeld, M; Weis, J J; Toshchakov, V et al. (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69:1477-82
Windsor, L J; Steele, D L (2001) Expression of recombinant matrix metalloproteinases in Escherichia coli. Methods Mol Biol 151:191-205
Caterina, J J; Shi, J; Kozak, C A et al. (2000) Characterization, expression analysis and chromosomal mapping of mouse matrix metalloproteinase-19 (MMP-19). Mol Biol Rep 27:73-9
Foster, K W; Frost, A R; McKie-Bell, P et al. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60:6488-95
Caterina, J; Shi, J; Sun, X et al. (2000) Cloning, characterization, and expression analysis of mouse enamelysin. J Dent Res 79:1697-703
Caterina, J J; Yamada, S; Caterina, N C et al. (2000) Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem 275:26416-22

Showing the most recent 10 out of 144 publications